Edwin George II

Edwin George II

egeorge@med.wayne.edu; aa3670@wayne.edu

313-745-4275 WSU; 313 576 3529 VAMC

313 745 4216 WSU; 313 576 1377 VAMC (fax)

Edwin George II

Narrative Bio

Dr. George joined the Wayne State University School of Medicine faculty in 1996, and he is Director of the Wayne State University Movement Disorders Center and also Director of the Movement Disorders Clinic at the John D. Dingell VA Medical Center. He is chairman of the Professional Advisory Board of the Michigan Parkinson's Foundation, and serves on the Movement Disorders Strategic Planning Committee of the American Academy of Neurology. He is Co-Director of the Neuropathophysiology curriculum for the Wayne State University School of Medicine.

Dr. George's research interests include clinical management of Parkinson's disease, tremor and dystonia, and he has been active in clinical trials of new medications for Parkinson's disease and dystonia. He is also involved in research on measuring the impact of neurological disease on patient function. Dr. George's laboratory research has focused on neuronal reaction to injury and neural regeneration. Dr. George has a Ph.D. in pharmacology, as well as an M.D., from Case Western Reserve University, and was a Grass Fellow in Neurophysiology at the Marine Biological Laboratory in Woods Hole, MA. He has lectured and written extensively on movement disorders, and has served as a consultant to U.S. and international pharmaceutical firms.

Office Address

8 D University Health Center 4201 St Antoine Detroit, MI 48201; John D Dingell VAMC Movement Disorders Clinic, John R Street, Detroit, MI, 48201

Awards & Honors

  • Listed in Best Doctors in America and Best Doctors in Michigan
  • Received the 2010 Successful REcruitment Award for the highest number of total matches of USA medical schools foe students matching in Neurology
  • Elected chair of the Board of Directors, Michigan Parkinsons Disease Foundation in 2010
  • John Woodruff Simpson Fellowship for Study in Biophysics and Medicine
  • Noether Memorial Fund Award for Excellence in Therapeutics
  • Clinician Scientist Award, Johns Hopkins School of Medicine
  • Wayne State University College Teaching Award
     

Other Information

New research funding awarded in 2011

“Flex: An Open-Label, Non-Inferiority Study Evaluating the Efficacy and Safety of Two Injection Schedules of Xeomin (incobotulinumtoxin A) [Short Flex vs Long Flex] in Subjects with Cervical Dystonia with< 10 Weeks of Benefit from OnabotulinumtoxinA Treatment.” Sponsor: Merz Pharmaceuticals. Edwin George, PI, Mary Shaya, co-PI.

Merz Pharmaceuticals LLC, CD FLEX: An Open-Label, Non-Inferiority Study Evaluating the Efficacy and Safety of Two Injection Schedules of Xeomin® (incobotulinumtoxinA) [Short Flex vs. Long Flex] in Subjects with Cervical Dystonia with < 10 Weeks of Benefit from OnabotulinumtoxinA Treatment. Q4,2011-Q3,2016, local PI: E.B. George

New research funding awarded in 2010

 “Effect of rasagiline (AzilectÒ) on Tissue Injury in Patients with Parkinson’s Disease: An Exploratory non-conventional multi-modal MRI study.” Sponsor: Teva Neuroscience. Omar Khan, PI, Edwin George, co-PI.
 
 

 

 

Undergraduate

Amherst College, B.A., 1980

Graduate

Case Western Reserve University, Ph.D. (Pharmacology), 1985

Medical

Case Western Reserve University, M.D., 1987

Position Title

Assistant Professor of Neurology; Director, Movement Disorders Center

Internships

Sinai Hospital of Baltimore, 1987-1988

Residency

The Johns Hopkins Hospital, 1988-1991

Specialties

Movement disorders program

Fellowships

Grass Fellowship in Neurophysiology, Marine Biological Laboratory, Woods Hole, Massachusetts, 1986

Prior Appointments

Instructor of Neurology, Johns Hopkins University, Baltimore, MD, 1991-1993

Assistant Professor of Neurology, Johns Hopkins University, Baltimore, MD, 1993-1996

Interests